NOVEL ANTI-GLYCAN ANTIBODY AND USE THEREOF

BISPECIFIC ANTI-HUMAN A-BETA/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

ANTI-LYMPHOTOXIN BETA RECEPTOR ANTIBODIES AND METHODS OF USE THEREOF

ANTIBODIES BINDING CD40 AND USES THEREOF

Method of treating type 1 interferon (IFN)-mediated disease using a subcutaneous dosing regimen comprising anifrolumab

COILED COIL IMMUNOGLOBULIN FUSION PROTEINS AND COMPOSITIONS THEREOF

HUMANIZED ANTIBODY SPECIFIC FOR CD22 AND CHIMERIC ANTIGEN RECEPTOR USING THE SAME

TIM-3-targeting antibodies and uses thereof

BISPECIFIC ANTIBODY TREATMENT OF LYMPHOID MALIGNANT NEOPLASM CONDITIONS

CHECKPOINT BLOCKADE AND MICROSATELLITE INSTABILITY

SINGLE DOMAIN ANTIBODIES AGAINST CD33

NATRIURETIC PEPTIDE RECEPTOR 1 ANTIBODIES AND METHODS OF USE

USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS IMPERFECTA

High-affinity capsule-specific human monoclonal antibody

Human immunodeficiency virus neutralizing antibodies and methods of use thereof

RSV-specific antibodies and functional parts thereof

One-Step Labeling of Antibodies to High Specific Activity with Actinium-225

Anti-transferrin receptor antibody-PMO conjugates for inducing DMD exon 44 skipping

METHODS FOR FORMULATING ANTIBODY DRUG CONJUGATE COMPOSITIONS

Claudin 18.2 T cell-antigen couplers and uses thereof

COMBINATION THERAPY FOR CANCER

COMPOSITIONS AND METHODS FOR CD30 GENE MODIFICATION

T CELL RECEPTOR-DEFICIENT CHIMERIC ANTIGEN RECEPTOR T-CELLS AND METHODS OF USE THEREOF

EXTRACELLULAR VESICLE-ASO CONSTRUCTS TARGETING STAT6

USE OF A COMBINATION COMPRISING A BTK INHIBITOR FOR TREATING CANCERS

METHODS OF USING OX40 LIGAND ENCODING POLYNUCLEOTIDES

PRODUCTION OF HETEROMULTIMERIC PROTEINS

USE OF INHIBITORS OF ADAM12 AS ADJUVANTS IN TUMOR THERAPIES

OPTIMIZED ANTIBODIES TARGETING TROP2 AND USES THEREOF

HUMANIZED ANTIBODY, CHIMERIC ANTIGEN RECEPTOR, NUCLEIC ACID, VECTOR, CELL AND USE

METHODS AND MATERIALS FOR ASSESSING RESPONSE TO PLASMABLAST- AND PLASMA CELL-DEPLETING THERAPIES

IMMUNOSTIMULATORY AGONISTIC ANTIBODIES FOR USE IN TREATING CANCER

ANTIBODIES AND ANTIBODY-DRUG CONJUGATES SPECIFIC FOR CD123 AND USES THEREOF

EGFR BINDING MOLECULES

BISPECIFIC ANTIBODY AGAINST ALPHA-SYN/IGF1R AND USE THEREOF

PROTEASE CLEAVABLE BISPECIFIC ANTIBODIES AND USES THEREOF

SINGLE DOMAIN ANTIBODIES TO PROGRAMMED CELL DEATH PROTEIN 1 (PD-1)

COMBINATION THERAPY WITH TARGETED 4-1BB (CD137) AGONISTS

MONOCLONAL ANTIBODIES AND METHODS FOR USING SAME

ANTI-CD98hc ANTIBODY

ANTI-CLAUDIN18.2 AND CD3 BISPECIFIC ANTIBODY AND USE THEREOF

COMPOSITIONS AND METHODS FOR MODULATING FLRT3 MEDIATED SIGNAL TRANSDUCTION

PHARMACEUTICAL FORMULATIONS OF FCRN INHIBITORS SUITABLE FOR SUBCUTANEOUS ADMINISTRATION

MULTISPECIFIC ANTIBODIES TARGETING IL-13 AND IL-18

Method of treating rheumatoid arthritis using antibodies to oxidized phospholipids

METHODS AND COMPOSITIONS FOR EVALUATING AND TREATING FIBROSIS

Antigen Binding Molecules Targeting SARS-CoV-2

Antigen binding molecules targeting SARS-CoV-2

COVID-19 ANTIBODIES AND USES THEREOF

IL-21 polypeptides and targeted constructs

Recombinant Fusion Proteins Comprising Interleukin-18-Binding Protein and Antigen Binding Fragment to Serum Albumin, and Compositions and Uses Thereof

COMPOSITIONS AND METHODS FOR PREDICTING RESPONSE TO NAPI2B-TARGETED THERAPY

Method of administering Lapatinib to a canine to treat bladder cancer harboring a BRAF mutation

CD70+ SOLID TUMOR THERAPY USING GENETICALLY ENGINEERED T CELLS TARGETING CD70

COMPOUND FOR INCREASING EFFICACY OF VIRAL VECTORS

COMPOSITIONS AND METHODS FOR TREATMENT OF SKIN CANCERS

METHODS AND COMPOSITIONS FOR DELIVERING MRNA CODED ANTIBODIES

ASSESSMENT OF INTESTINAL BARRIER FUNCTION TO IMPROVE TREATMENT OF INFLAMMATORY BOWEL DISEASE

METHODS FOR SELECTIVELY MODULATING THE ACTIVITY OF DISTINCT SUBTYPES OF CELLS

PHARMACEUTICAL COMPOSITIONS OF ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES AND METHODS OF USE

USE OF LANCL1 AND ANTIBODIES THEREOF AS A DIAGNOSTIC AND THERAPEUTIC TARGET FOR THE MANAGEMENT AND TREATMENT OF CANCER

BISPECIFIC ANTIBODY

METHODS AND ANTIBODIES IN TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)

CD40 AGONISTIC ANTIBODY AND METHOD OF USE

METHODS FOR TREATING SEVERE ASTHMA IN PATIENTS WITH NASAL POLYPOSIS

NANOBODY BASED IMAGING AND TARGETING OF ECM IN DISEASE AND DEVELOPMENT

BISPECIFIC ANTIBODY FOR ICOS AND PD-L1

Antibodies That Bind Human Cannabinoid 1 (CB1) Receptor

Anti-TSPAN8/anti-CD3 bispecific antibody and anti-TSPAN8 antibody

THERAPEUTIC AGENTS AND USES THEREOF

TGFbeta1-BINDING IMMUNOGLOBULINS AND USE THEREOF

Anti-ANGPTL3 antibodies suitable for high concentration compositions and subcutaneous administration

CONFORMATION-SPECIFIC ANTIBODIES THAT BIND TAU PROTEIN AND USES THEREOF

CROSS-REACTIVE CORONAVIRUS ANTIBODIES AND USES THEREOF

ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 191P4D12 PROTEINS

MUSCLE-TARGETING COMPLEXES AND USES THEREOF IN TREATING MUSCLE ATROPHY

ETAR ANTIBODY, AND PHARMACEUTICAL COMPOSITIONS AND USE THEREOF

MRNA COMBINATION THERAPY FOR THE TREATMENT OF CANCER

COMBINATION of ATR KINASE INHIBITORS and PD-1/PD-L1 INHIBITORS

METHODS OF TREATING ANKYLOSING SPONDYLITIS USING IL-17 ANTAGONISTS

GROUP B STREPTOCOCCUS POLYSACCHARIDE-PROTEIN CONJUGATES, METHODS FOR PRODUCING CONJUGATES, IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATES, AND USES THEREOF

METHODS OF STIMULATING AN ANTI-TUMOR RESPONSE USING A SELECTIVE GLUCOCORTICOID RECEPTOR MODULATOR

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING MTOR-SIGNALING INHIBITOR AS ACTIVE INGREDIENT

Therapeutic antibodies against ROR-1 protein and methods for use of same

BIOMARKERS PREDICTING CLINICAL RESPONSE OF A VEGF-A INHIBITORY DRUG IN CANCER PATIENTS, METHOD FOR THEIR SELECTION AND USE

Gene-regulating compositions and methods for improved immunotherapy

CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS

COMBINATION THERAPY WITH FAP-TARGETED CD40 AGONISTS

Anti-PCSK9 antibodies

BINDING MOLECULES SPECIFIC FOR CD73 AND USES THEREOF

PLASMA KALLIKREIN BINDING PROTEINS

METHOD FOR TREATING A GD2 POSITIVE CANCER

SUBCUTANEOUS ANTI-C5AR ANTAGONIST TREATMENT REGIMEN WITH AVDORALIMAB

METHODS, THERAPIES AND USES FOR TREATING CANCER

Antibodies Directed Against CD127

ANTI-CD147 ANTIBODY

NOVEL ANTI-LILRB4 ANTIBODIES AND DERIVATIVE PRODUCTS

CHIMERIC ANTIGEN RECEPTORS (CARs), COMPOSITIONS AND METHODS THEREOF

ANTIBODY FRAGMENT AGAINST FOLR1

ANTI-IL-2 ANTIBODIES AND COMPOSITIONS AND USES THEREOF

IL-21 polypeptides and targeted constructs

LIGANDS TO GM-CSF OR GM-CSF-RECEPTOR FOR USE IN LEUKEMIA IN A PATIENT HAVING UNDERGONE ALLO-HCT

ANTI-GARP/TGF-BETA ANTIBODIES AND METHODS OF USE

Anti-PD-1/VEGFA bifunctional antibody, pharmaceutical composition thereof

Tau Immunotherapy

YEAST-BASED IMMUNOTHERAPY AGAINST CLOSTRIDIUM DIFFICILE INFECTION

LENTIVIRAL VECTOR EXPRESSING MEMBRANE-ANCHORED OR SECRETED ANTIBODY

ANTI-HBV ANTIBODIES AND METHODS OF USE

TARGETED HETERODIMERIC FC FUSION PROTEINS CONTAINING IL-15/IL-15RA AND NKG2D ANTIGEN BINDING DOMAINS

DUAL CONJUGATION PROCESS FOR PREPARING ANTIBODY-DRUG CONJUGATES

ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS

ANTI-CD20 ANTIBODY FORMULATION AND USE OF ANTI-CD20 ANTIBODY FOR TREATMENT OF CD20 POSITIVE DISEASES

VISTA MODULATORS FOR DIAGNOSIS AND TREATMENT OF CANCER

FUSION PROTEIN WITH IMMUNOENHANCING ACTIVITY

Immune complex

Vaccine Compositions and Antibodies For Lyme Disease

COMPOSITIONS AND METHODS COMPRISING R-SPONDINS FOR TREATMENT OF TUMORS

TREATMENT REGIMEN FOR CANCER USING IMMUNOMODULATION

METHODS OF DETECTING TRBC1 OR TRBC2

Glycan-Interacting Compounds and Methods of Use

Use of CD2/5/7 Knock-Out Anti-CD2/5/7 Chimeric Antigen Receptor T cells Against T Cell Lymphomas and Leukemias

COMBINATION THERAPY USING AN IL-2 RECEPTOR AGONIST AND AN IMMUNE CHECKPOINT INHIBITOR

ANTITUMOR IMMUNE CHECKPOINT REGULATOR ANTAGONISTS

CHIMERIC RECEPTORS AND METHODS OF USE THEREOF

METHODS AND COMPOSITIONS FOR TREATING SYSTEMIC MASTOCYTOSIS

METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASES OR CONDITIONS RELATED TO INNATE LYMPHOID CELLS

Neutralizing antibodies to the αvβ8 integrin complex for immunotherapy

PD-1 BINDING ANTIBODIES AND USES THEREOF

ANTI-CD83 CAR-T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUPTION

ANTI-SEZ6L2 ANTIBODIES AND ANTIBODY DRUG CONJUGATES

OLIGONUCLEOTIDES FOR REDUCTION OF PD-L1 EXPRESSION

METHOD OF TREATING TENDINOPATHY USING INTERLEUKIN-17 (IL-17)

TAU-BINDING ANTIBODIES

ANTIBODIES TO ALPHA-SYNUCLEIN AND USES THEREOF

Anti-Abeta Antibodies

CELL

IL-2R-BETA-GAMMA BINDING COMPOUNDS

ANTI-GLP1R ANTIBODY-TETHERED DRUG CONJUGATES COMPRISING GLP1 PEPTIDOMIMETICS AND USES THEREOF

METHODS FOR TREATING CANCERS WITH ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 191P4D12 PROTEINS

Immunoconjugates and methods

Anti-CTLA-4 antibodies and methods of use thereof

CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY

METHODS OF STIMULATING BONE GROWTH WITH ABALOPARATIDE AND DENOSUMAB

TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY (TNFRSF) AGONISTS, SPHERICAL NUCLEIC ACID (SNA) TLR9 AGONISTS AND CHECKPOINT INHIBITORS FOR ANTITUMOR THERAPY

METHODS TO PREVENT HIGH-GRADE SEROUS OVARIAN CANCER AND BREAST CANCER BY ADMINISTERING ANTIPROGESTINS

PHARMACEUTICAL COMPOSITION FOR TREATING TUMORS

INERT FORMAT

ANTIBODY BINDING TO HUMAN CD38, PREPARATION METHOD THEREOF, AND USE THEREOF

METHODS FOR TREATING MULTIPLE SCLEROSIS WITH OCRELIZUMAB

PD-L1 and OX40 binding proteins for cancer regulation

Early intervention methods to prevent or ameliorate toxicity

ANTI-CD93 CONSTRUCTS AND USES THEREOF

Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disorders

Anti-BTN3A antibodies and their use in treating cancer or infectious disorders

Bifunctional Proteins Combining Checkpoint Blockade for Targeted Therapy

EGFR x CD28 MULTISPECIFIC ANTIBODIES

Anti-CD3 antibodies and uses thereof

Human Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), and Uses Thereof

Humanized Anti-TDP-43 Binding Molecules and Uses Thereof

ANTI-PCRV ANTIBODIES THAT BIND PCRV, COMPOSITIONS COMPRISING ANTI-PCRV ANTIBODIES, AND METHODS OF USE THEREOF

PHARMACEUTICAL COMPOSITION COMPRISING CELL EXPRESSING CHIMERIC RECEPTOR

IMMUNOGENS DERIVED FROM SARS-COV2 SPIKE PROTEIN

Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT

CANCER PEPTIDE VACCINE AND METHOD OF PREPARING THE SAME

METHODS OF TREATING GENERALIZED PUSTULAR PSORIASIS (GPP) USING IL-17 ANTAGONISTS

METHODS OF TREATING PSORIASIS USING IL-17 ANTAGONISTS

CYTOKINE STORM SUPPRESSOR, METHOD FOR USING CYTOKINE STORM SUPPRESSOR AND SCREENING METHOD

PD-L1 EXPRESSING HEMATOPOIETIC STEM CELLS AND USES

Anti-Fibrotic Combination

Compositions and Methods for Treating Cancer

Nucleic acids encoding, and methods of producing, antibodies that bind human chemokine (C—C motif) receptor 8 (CCR8)

EGFR ANTIGEN BINDING FRAGMENTS AND COMPOSITIONS COMPRISING SAME

FORMULATION FOR ANTI-ALPHA4BETA7 ANTIBODY

ANTI-B7H4 ANTIBODY, AND BISPECIFIC ANTIBODY AND USE THEREOF

Anti-B7H3 Antibodies for the Treatment of Cancer

MULTISPECIFIC ANTIBODIES FOR IMMUNO-ONCOLOGY

Combination Treatment Method with E10A and PD1 Monoclonal Antibody for Tumor and Pharmaceutical Application

ANTIBODY CONSTRUCTS FOR DLL3 AND CD3

ANTI-TREM2 ANTIBODIES AND METHODS OF USE THEREOF

Antibody targeting CD47 and application thereof

CHIMERIC ANTIGEN RECEPTOR MODIFIED T-CELLS (CAR-T) FOR THE TREATMENT OF HEMATOLOGICAL AND SOLID TUMOR CANCERS

USES OF MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS

Method of Treating Psoriasis with IL-23 Specific Antibody

LONG-ACTING ANTI-IL31 ANTIBODIES FOR VETERINARY USE

ANTI-ACTIVIN A ANTIBODIES AND USES THEREOF

Agents, Uses and Methods for the Treatment of Synucleinopathy

CHIMERIC ANTIGEN RECEPTORS (CAR) AND METHODS FOR MAKING AND USING THE SAME

MYELIN OLIGODENDROCYTE GLYCOPROTEIN-SPECIFIC PEPTIDE FOR THE TREATMENT OR PREVENTION OF MULTIPLE SCLEROSIS

Site-specific antibody conjugation and its use

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

BISPECIFIC ANTIBODY-DRUG CONJUGATES TARGETING EGFR AND MUC1 AND USES THEREOF

Long-Lived Gadolinium Based Tumor Targeted Imaging and Therapy Agents

METHODS FOR CULTURING CELLS EXPRESSING ROR1-BINDING PROTEIN

Combination Of The Application Of Antibodies For Immunostimulation Together With Glucocorticoids

USE OF RILUZOLE, RILUZOLE PRODRUGS OR RILUZOLE ANALOGS WITH IMMUNOTHERAPIES TO TREAT CANCERS

NUCLEIC ACIDS ENCODING A POLYPEPTIDE COMPRISING A MODIFIED FC REGION OF A HUMAN IGG1 AND AT LEAST ONE HETEROLOGOUS ANTIGEN

Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy

HEMATOPOIETIC STEM CELL ENGRAFTMENT WITH A COMBINATION OF AGENTS

COMBINATION THERAPY FOR CANCERS WITH KRAS MUTATION

COMBINATION OF LURBINECTEDIN AND IMMUNE CHECKPOINT INHIBITOR

COMPOUNDS AND METHODS FOR TREATING CANCER

TREATMENT OF ER-NEGATIVE BREAST CANCER WITH AN PDGF-CC INHIBITOR AND AN ANTI-ESTROGEN

TL1A THERAPY COMPOSITIONS AND METHODS OF TREATMENT THEREWITH

HUMANIZED 3E10 ANTIBODIES, VARIANTS, AND ANTIGEN BINDING FRAGMENTS THEREOF

Modified Antibody

Antibodies and methods for making and using the same

FGFR3 ANTIBODIES AND METHODS OF USE

ANTI-TRKA ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, PREPARATION METHOD THEREOF, AND APPLICATION THEREOF

COMBINATION THERAPY OF CANCER INVOLVING MULTI-SPECIFIC BINDING PROTEINS THAT BIND NKG2D, CD16, AND A TUMOR-ASSOCIATED ANTIGEN

Bispecific Anti-PSMA x Anti-CD28 Antibodies and Uses Thereof

ANTIBODIES THAT BIND GAMMA-DELTA T CELL RECEPTORS

ANTI-PD1 ANTIBODIES AND THEIR USE AS THERAPEUTICS AND DIAGNOSTICS

Methods for treating myeloma by achieving therapeutically effective doses of anti-CD47 antibody

METHODS AND COMPOSITIONS FOR TREATING FIBROTIC DISEASES

METHODS OF TREATING NEW-ONSET PLAQUE TYPE PSORIASIS USING IL-17 ANTAGONISTS

METHODS FOR REDUCING MIGRAINE FREQUENCY IN A SUBJECT IN NEED THEREOF

METASTATIC CANCER TREATMENT OR PREVENTION

MODIFIED ANTI-VIRAL BINDING AGENTS

Antibodies that potently neutralize hepatitis B virus and uses thereof

Fusion Molecules of PSGL-1 or TSGL Anionic Domains to Checkpoint-Modulating Antibodies and Other Antibodies

COMPOSITIONS AND METHODS FOR IN VIVO GENERATION OF CAR EXPRESSING CELLS

COMPOSITIONS AND METHODS FOR ENGINEERING AND SELECTION OF CAR T CELLS WITH DESIRED PHENOTYPES

AGENTS DIRECTED AGAINST A CIS RGMA/NEOGENIN INTERACTION OR LIPID RAFTS AND USE OF THE SAME IN METHODS OF TREATMENT

COMBINATION THERAPY FOR TREATMENT OF CANCER

COMPOSITIONS AND METHODS FOR TREATING INFLAMMASOME RELATED DISEASES OR CONDITIONS

PREDICTING ADVERSE EVENTS FROM IMMUNOTHERAPY

REGULATORY B CELLS AND THEIR USES

ANTI-TMPRSS6 ANTIBODIES AND USES THEREOF

CLINICAL METHODS FOR USE OF HER2 BINDING MOLECULES

ANTIBODIES TO M(H)DM2/4 AND THEIR USE IN DIAGNOSING AND TREATING CANCER

MUC1* ANTIBODIES

METHOD FOR TREATING A GD2-POSITIVE CANCER

A NOVEL ANTIBODY BINDING SPECIFICALLY TO HUMAN CEACAM1/3/5 AND USE THEREOF

MULTI-SPECIFIC BINDING PROTEINS FOR CANCER TREATMENT

Chimeric polypeptide assembly and methods of making and using the same

NOVEL ANTI-CD137 ANTIBODIES AND USES THEREOF

Binding molecules against BCMA and uses thereof

METHODS OF TREATING AUTOIMMUNE DISEASE USING A DOMAIN ANTIBODY DIRECTED AGAINST CD40L

ANTI-MULLERIAN HORMONE RECEPTOR BINDING PEPTIDES

ANTIBODIES AGAINST HUMAN AND CANINE IL-13RA2

IL10RB binding molecules and encoding nucleic acids

IL27RAlpha binding molecules and methods of use

ANTAGONISTIC BIPARATOPIC ANTIBODIES THAT SPECIFICALLY BIND FIBROBLAST GROWTH FACTOR RECEPTOR 2 AND METHODS OF USING SAME

Anti-Inflammatory Polypeptides

PD-1 AND PD-L1 BINDING AGENTS

HUMANIZED MONOCLONAL ANTIBODIES AND METHODS OF USE FOR THE DIAGNOSIS AND TREATMENT OF COLON AND PANCREAS CANCER

ANTI-TREM2 ANTIBODIES AND METHODS OF USE THEREOF

BINDING MOLECULES AGAINST FRa

METHODS OF REVERSING CACHEXIA AND PROLONGING SURVIVAL COMPRISING ADMINISTERING A GDF15 MODULATOR AND AN ANTI-CANCER AGENT

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

ANTI-SARS CORONAVIRUS-2 SPIKE PROTEIN ANTIBODIES

RNA ENCODING AN ANTIBODY

ANTI-TM4SF1 ANTIBODY DRUG CONJUGATES AND METHODS OF USING SAME

ANTIBODY-DRUG CONJUGATE AND PREPARATION THEREOF

CELL/GENE THERAPIES TARGETING MAGE-A4 PEPTIDE

METHODS OF TREATING ANKYLOSING SPONDYLITIS USING IL-17 ANTAGONISTS

Vaccine for falciparum malaria

PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF POST-SURGICAL PAIN

Compositions and Methods Related to Multimodal Therapeutic Cell Systems for Cancer Indications

Anti-coagulation factor XI antibodies

ANTI-HER2/PD1 BISPECIFIC ANTIBODY

CD37-BINDING MOLECULES IMMUNOCONJUGATES THEREOF

ANTI-PD-L1 ANTIBODIES, COMPOSITIONS AND ARTICLES OF MANUFACTURE

BIFUNCTIONAL MOLECULES TARGETING PD-L1 AND TGF-BETA

B7-H4 ANTIBODY DOSING REGIMENS

DLL3 TARGETING CHIMERIC ANTIGEN RECEPTORS AND BINDING AGENTS

CHIMERIC ANTIGEN RECEPTOR CELLS TARGETING ROBO1, PREPARATION METHOD AND USE THEREOF

RECOMBINANT POLYCLONAL PROTEINS TARGETING COVID-19 AND METHODS OF USE THEREOF

NOVEL COMPOUNDS CAPABLE OF ANTAGONIZING ISLET AMYLOID POLYPEPTIDE (IAPP) INDUCED BETA-CELL DAMAGE AND IMPAIRED GLUCOSE TOLERANCE

Methods of Treatment Using Anti-IL-17A/F Antibodies

POLYPEPTIDES

COMPOSITIONS AND METHODS TO TARGET ANTI-TNF-ALPHA ANTIBODY

ANTI-FAM19A5 ANTIBODIES AND USES THEREOF

TGF-β3 specific antibodies and methods and uses thereof

METHODS AND COMPOSITIONS FOR THE GENERATION AND USE OF HUMANIZED CONFORMATION-SPECIFIC PHOSPHORYLATED TAU ANTIBODIES

PREVENTION OF AXONAL DAMAGE USING ANTIBODY BINDING TO AMYLOID BETA 1-42

PD-1 mutant polypeptide and preparation and application thereof

DUAL CYTOKINE FUSION PROTEINS COMPRISING MULTI-SUBUNIT CYTOKINES

ENHANCING ANTI-CANCER ACTIVITY OF IMMUNOMODULATORY FC FUSION PROTEINS

Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy

CONJUGATES OF BIOLOGICALLY ACTIVE MOLECULES TO FUNCTIONALIZED POLYMERS

PREPARATION SPECIFICALLY BOUND WITH CD137 AND USE THEREOF

VACCINES BASED ON MUTANT CALR AND JAK2 AND THEIR USES

INTRATUMORALLY INJECTED YEAST VACCINE

Saposin-A derived peptides and uses thereof

METHODS OF TREATMENT OF NON-SMALL-CELL LUNG CARCINOMA USING TELISOTUZUMMAB VEDOTIN AND OSIMERTINIB

METHODS AND COMPOSITIONS FOR INCREASING ALPHA-L-IDURONIDASE ACTIVITY IN THE CNS

CD20-PD1 BINDING MOLECULES AND METHODS OF USE THEREOF

ANTI-TETRODOTOXIN ANTIBODY Y126C, AND PREPARATION METHOD AND USE THEREOF

H1.0K180ME2 ANTIBODIES, METHODS OF MAKING AND USES THEREOF

ANTI-HER2 ANTIBODY AND USE THEREOF

Anti-CD73 antibodies and use thereof

NOVEL BISPECIFIC ANTI-CD3/CD20 POLYPEPTIDE COMPLEX FORMULATION

PHARMACEUTICAL COMPOSITIONS OF HUMANIZED ANTI-CD40 ANTIBODIES

Methods of reducing or hindering development of ischemia-reperfusion injury due to kidney transplantation with an antibody that inhibits granulocyte-colony stimulating factor (G-CSF) signaling

Interferon-gamma R2 (IFNGR2) binding molecules comprising single-domain antibodies and method of use thereof to treat autoimmune and inflammatory diseases

IL12 receptor synthetic cytokines and methods of use

HUMANIZED ANTI-IL-4Ra SINGLE DOMAIN ANTIBODY AND APPLICATION THEREOF

COMPOSITIONS AND METHODS FOR TREATMENT OF THYROID EYE DISEASE